United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for NewGenIvf Group Ltd? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -39.05% | - | -196.77% | -273.78% | -339.09% | -329.47% |
|---|---|---|---|---|---|---|
| ROA | -13.01% | -9.7% | -9.84% | -13.69% | -16.95% | -16.47% |
| Gross Margin | 33.62% | 32.9% | 31.02% | 30.19% | 28.46% | 28.62% |
| Net Margin | -9.66% | -5.87% | -5.88% | -7.84% | -9.68% | -9.36% |
| Total Assets | $3,577.74K | $3,829.94K | $4,102.58K | $4,397.31K | $4,715.94K | $5,056.96K |
| Net Income | -$524.64K | -$359.36K | -$390.23K | -$581.78K | -$772.55K | -$804.96K |